• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因内的多态性与散发性甲状腺髓样癌的风险。

Polymorphisms Within the Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.

机构信息

Department of Biology, University of Pisa, Pisa, Italy.

Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Cisanello, Pisa, Italy.

出版信息

Thyroid. 2020 Nov;30(11):1579-1588. doi: 10.1089/thy.2019.0352. Epub 2020 May 5.

DOI:10.1089/thy.2019.0352
PMID:32228166
Abstract

Sporadic medullary thyroid carcinoma (sMTC) is an uncommon neoplasia arising from the calcitonin-producing parafollicular cells of the thyroid. Previous studies evaluated whether single nucleotide polymorphisms (SNPs) within (a pivotal proto-oncogene for this disease) are associated with the risk for developing sMTC, but the results are inconclusive. In this work, we evaluated the association of -SNPs c.74-126G>T (rs2565206), p.Gly691Ser (rs1799939, G>A), p.Leu769 = (rs1800861, G>T), p.Ser836 = (rs1800862, C>T), and p.Ser904 = (rs1800863, C>G) (listed in the order of their chromosomal location) with sMTC. This is one of the largest casecontrol association studies carried out on sMTC, including 585 sMTC cases (negative for germline mutations within ), 1529 patients affected by sporadic nonmedullary thyroid carcinoma (sNMTC), and 989 healthy controls, from central and southern Italy and collected in the period 2000-2017. sNMTC patients showed similar genotype and allele frequencies compared with healthy controls. On the other hand, among sMTC patients, the T-allele of p.Leu769 = was less frequent (OR = 0.70 [CI 0.58-0.84],  = 1.9 × 10) and rare homozygotes TT showed an OR = 0.32 ([CI 0.17-0.60],  = 2.3 × 10). Moreover, a statistically significant excess of the haplotype 2 (characterized by the alleles T-G-G-C-C of the listed SNPs) was observed ( = 3.9 × 10). The SNPs were not associated with the expression of mRNA, that is, they did not exert an effect in as quantitative trait locus (cis-eQTL). However, a strong eQTL association was found for p.Leu769 = and the neighboring gene ( = 9.3 × 10; effect-size = -0.65), whose function in cancer is unknown. This study shows that specific haplotypes, in particular haplotype 2 and the T-allele of p.Leu769 = , are associated with a reduced risk of sMTC in Italians.

摘要

散发性甲状腺髓样癌(sMTC)是一种罕见的肿瘤,起源于甲状腺的降钙素产生的滤泡旁细胞。先前的研究评估了 (该疾病的关键原癌基因)内的单核苷酸多态性(SNPs)是否与发生 sMTC 的风险相关,但结果尚无定论。在这项工作中,我们评估了 -SNPs c.74-126G>T(rs2565206)、p.Gly691Ser(rs1799939,G>A)、p.Leu769 = (rs1800861,G>T)、p.Ser836 = (rs1800862,C>T)和 p.Ser904 = (rs1800863,C>G)(按染色体位置顺序列出)与 sMTC 的关联。这是在 sMTC 上进行的最大的病例对照关联研究之一,包括来自意大利中部和南部的 585 例 sMTC 病例( 种系突变阴性)、1529 例散发性非甲状腺髓样癌(sNMTC)患者和 989 例健康对照者,收集时间为 2000-2017 年。sNMTC 患者与健康对照组的基因型和等位基因频率相似。另一方面,在 sMTC 患者中,p.Leu769 = 的 T 等位基因频率较低(OR = 0.70 [CI 0.58-0.84],  = 1.9 × 10),罕见的纯合子 TT 显示 OR = 0.32 [CI 0.17-0.60],  = 2.3 × 10)。此外,观察到列表中 SNPs 的等位基因 T-G-G-C-C 特征的 2 号单倍型(haplotype 2)显著过量(  = 3.9 × 10)。这些 SNP 与 mRNA 的表达无关,即它们没有作为数量性状基因座(cis-eQTL)发挥作用。然而,发现 p.Leu769 = 和邻近基因 (  = 9.3 × 10;效应大小 = -0.65)之间存在很强的 eQTL 关联,其在癌症中的功能尚不清楚。本研究表明,特定的 单倍型,特别是单倍型 2 和 p.Leu769 = 的 T 等位基因,与意大利人群中 sMTC 风险降低相关。

相似文献

1
Polymorphisms Within the Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.原癌基因内的多态性与散发性甲状腺髓样癌的风险。
Thyroid. 2020 Nov;30(11):1579-1588. doi: 10.1089/thy.2019.0352. Epub 2020 May 5.
2
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.甲状腺髓样癌 (MTC) 和 RET 原癌基因:家族性病例的突变谱和散发性病例研究的荟萃分析。
Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8.
3
Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌背景下RET基因多态性和单倍型分析
Thyroid. 2006 Apr;16(4):411-7. doi: 10.1089/thy.2006.16.411.
4
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.散发性甲状腺髓样癌中的RET基因分型:一项大型意大利研究系列
Clin Endocrinol (Oxf). 2008 Sep;69(3):418-25. doi: 10.1111/j.1365-2265.2008.03218.x. Epub 2008 Feb 11.
5
The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.性别、年龄和RET基因多态性对C细胞增生和甲状腺髓样癌的影响。
Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.
6
Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.伊朗甲状腺髓样癌患者中RET原癌基因外显子10的突变谱倾斜
Tumour Biol. 2015 Jul;36(7):5225-31. doi: 10.1007/s13277-015-3179-7. Epub 2015 Feb 20.
7
Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.葡萄牙人群中RET基因多态性和单倍型与甲状腺乳头状癌的关联:一项病例对照研究
PLoS One. 2014 Oct 17;9(10):e109822. doi: 10.1371/journal.pone.0109822. eCollection 2014.
8
The correlation between the expression of ATF4 and procalcitonin combined with the detection of mutation and the pathological stage and clinical prognosis of medullary thyroid carcinoma.探讨 ATF4 表达与降钙素联合检测在甲状腺髓样癌突变和病理分期及临床预后中的相关性。
Can J Physiol Pharmacol. 2022 Jan;100(1):19-25. doi: 10.1139/cjpp-2021-0316. Epub 2021 Nov 25.
9
A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation.一项关于伴有体细胞RET突变的散发性甲状腺髓样癌10年生存率的队列研究。
Kaohsiung J Med Sci. 2016 Nov;32(11):545-551. doi: 10.1016/j.kjms.2016.08.012. Epub 2016 Oct 14.
10
Modifying impact of gene haplotypes on medullary thyroid carcinoma clinical course.改变基因单倍型对甲状腺髓样癌临床病程的影响。
Endocr Relat Cancer. 2018 Apr;25(4):421-436. doi: 10.1530/ERC-17-0452. Epub 2018 Jan 31.

引用本文的文献

1
Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer.神经营养因子基因IVSI - 663多态性而非RET变异与乳腺癌风险增加相关。
Lab Med. 2025 Jul 11;56(4):351-359. doi: 10.1093/labmed/lmae097.
2
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .甲状腺髓样癌的分子基础与自然史:(几乎)都与……有关 。 (你提供的原文最后不完整,所以译文也只能到这个程度)
Cancers (Basel). 2023 Oct 5;15(19):4865. doi: 10.3390/cancers15194865.
3
Design of new drugs for medullary thyroid carcinoma.
甲状腺髓样癌新药的设计
Front Oncol. 2022 Dec 5;12:993725. doi: 10.3389/fonc.2022.993725. eCollection 2022.
4
Modifier Role of Common Variants in Sporadic Medullary Thyroid Carcinoma.散发性髓样甲状腺癌常见变异的修饰作用。
Int J Mol Sci. 2021 Oct 30;22(21):11794. doi: 10.3390/ijms222111794.